- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Multiple myeloma
- Meeting Date: November 2022
- Public Summary Document (PSD) November 2022 PBAC Meeting - (PDF 1.2MB)
- Public Summary Document (PSD) November 2022 PBAC Meeting - (Word 366KB)
Selinexor – November 2022
Selinexor: Tablet 20 mg; Xpovio®
Last updated
3 March 2023